Neoplasia Clinical Trial
Official title:
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia: a Randomised Controlled Trial - The NOVEL Trial
The researchers involved in this new study are interested in whether giving a HPV vaccine to women at the same time as conisation can lead to a greater rate of HPV clearance compared to conisation on its own, and a result reduce the occurrence of further infection and high grade CIN. The study will do this by using a specific HPV vaccine called Gardasil 9™ which protects against 9 types of HPV infection (types 6, 11, 16, 18, 31, 33, 45, 52 and 58).
The human papilloma virus (HPV) can cause high grade intra-epithelial neoplasia (CIN) in
women, a condition where there are abnormal cells on the surface of the cervix (the opening
to the vagina from the womb). High grade CIN can develop into cervical cancer, and standard
treatment is a surgical procedure called conisation, where a scalpel or laser is used to
remove a cone-shaped piece of the cervix containing the abnormal cells. HPV vaccines are
routinely used in adolescent girls as part screening programmes to prevent cervical cancer
(12-18 years of age in the UK).
The NOVEL study will compare the vaccine approach with standard treatment in a randomised
controlled trial, where eligible women will be randomly allocated to one of the following:
Arm 1: Local Cervical treatment and vaccination with Gardasil 9, followed by additional
vaccinations 2 and 6 months after conisation Arm 2: Local Cervical Treatment and Observation
This study is for women aged 18-55 years of age with biopsy confirmed high-grade CIN. 1000
women will be recruited at colposcopy clinics in the UK, Finland and Sweden. Women will be
followed up for a maximum of two and a half years.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00339989 -
Cervical Cancer Early Endpoints and Determinants
|
||
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Completed |
NCT02065297 -
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
|
||
Recruiting |
NCT02049658 -
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
|
||
Recruiting |
NCT02049645 -
The Suitability of Sniff Dog as a Tool in Screening Tumors
|
||
Completed |
NCT01523912 -
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
|
Phase 4 | |
Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
Enrolling by invitation |
NCT00792649 -
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
|
N/A | |
Recruiting |
NCT05158712 -
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
|
||
Completed |
NCT01962103 -
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT01456143 -
Optical Imaging of Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04341181 -
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
|
Phase 2 | |
Recruiting |
NCT02925234 -
The Drug Rediscovery Protocol (DRUP Trial)
|
Phase 2 |